Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study
- DOI
- 10.1093/bjd/ljae454
- Published
- 2024-11-20
- Container
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/bjd/ljae454,
title = {Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study},
author = {Duc Binh Phan and Hugo Jourdain and Miguel Angel Descalzo-Gallego and Alicia González-Quesada and Mahmoud Zureik and Raquel Rivera-Díaz and Antonio Sahuquillo-Torralba and Mark Lunt and Ignacio Garcia-Doval and Emilie Sbidian and Richard B Warren and Zenas Z N Yiu},
year = {2024},
journal = {British Journal of Dermatology},
doi = {10.1093/bjd/ljae454},
url = {https://doi.org/10.1093/bjd/ljae454}
}RIS
TY - JOUR TI - Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study AU - Duc Binh Phan AU - Hugo Jourdain AU - Miguel Angel Descalzo-Gallego AU - Alicia González-Quesada AU - Mahmoud Zureik AU - Raquel Rivera-Díaz AU - Antonio Sahuquillo-Torralba AU - Mark Lunt AU - Ignacio Garcia-Doval AU - Emilie Sbidian AU - Richard B Warren AU - Zenas Z N Yiu PY - 2024 JO - British Journal of Dermatology DO - 10.1093/bjd/ljae454 UR - https://doi.org/10.1093/bjd/ljae454 ER -
APA
Phan, D. B., Jourdain, H., Descalzo-Gallego, M. A., González-Quesada, A., Zureik, M., Rivera-Díaz, R., Sahuquillo-Torralba, A., Lunt, M., Garcia-Doval, I., Sbidian, E., Warren, R. B., & Yiu, Z. Z. N. (2024). Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae454
Source records
- crossref · retrieved 2026-11-03T11:10:42.584Z